See what your DNA file can read before you pay. Free, on your own device. Check your file free →
Deutsch Sample report Support Log in
aimostı Check your file

Every finding in your report comes from someone else's published work.

We restate authoritative, openly-licensed, version-pinned sources, and we name each one on the finding it produced. Here's exactly how that works.

The two-axis rule

We never collapse "how sure is the field?" and "how much does it matter?" into one score. That's how consumer genetics misleads. Every clinical finding shows evidence (ClinVar's own review stars) and effect (penetrance / effect size) side by side, so a big effect can never hide thin evidence, and vice-versa.

Pinned, attributed sources

Your report footer lists the exact version of every source it restates. Re-open it in a year and it renders identically: a frozen, attributable snapshot.

  • ClinVar: variant–condition interpretations (we use ≥2★ by default)
  • ACMG SF v3.3: the actionable-gene panel and its per-gene reporting rules (how its 84 genes were chosen)
  • CPIC: gene–drug prescribing guidance (pharmacogenomics)
  • GWAS Catalog: the strict gate for wellness traits
  • ClinGen: gene–disease validity and adult actionability, which choose the genes of the wider ClinVar screen and name its conditions
  • PGS Catalog: the published polygenic scores, each named by its identifier
  • gnomAD: population frequency · PhyloTree: mtDNA lineages

The Frontier firewall

The Frontier module is where we relax the evidence bar to show you the interesting, biohacker-relevant variants: alcohol-flush and caffeine metabolism, the natural short-sleeper genes, longevity curios, and the over-hyped classics we keep in to set the record straight (the “warrior gene”, the serotonin-transporter “depression gene”). We do not relax the sourcing bar (every entry still cites a real study), and we compensate with loud, mandatory caveats:

  • Walled off from your clinical findings: a Frontier reading never feeds into or alters a clinical result
  • A per-entry evidence-strength tier, from replicated down to contested and over-hyped
  • A distinct visual register (never styled like a clinical finding) and a persistent "emerging research" banner
  • A "what this isn't" line on every card
Across the whole product, exploratory surfaces are drawn with a dashed edge and carry their name: Frontier, or the Fringe. Colour never marks them on its own, and no clinical finding is ever drawn that way.

The full methodology →   See a sample report →